Pgiam/iStock via Getty Images
UBS has upgraded Option Care Health (NASDAQ:OPCH) to Buy from Neutral, citing an attractive valuation setup in the infusion services provider following the company’s Q1 2025 results, which exceeded Street forecasts.
UBS analyst AJ Rice argued that the Bannockburn, Illinois-based firm’s